Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study

Not Applicable

Completed

Conditions: Coronary Artery Disease
Coronary Artery Chronic Total Occlusion

Interventions: Device: BridgePoint Medical System (CrossBoss Catheter, Stingray Catheter, Entera Guidewire)

First Posted Date: 2008-12-03

Last Posted Date: 2021-01-26

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 42

Registration Number: NCT00801710

Locations: 🇩🇪
Main Taunus Hospital, Bad Soden, Germany
🇩🇪
Klinikum Darmstadt, Darmstadt, Germany
🇩🇪
CardioVascular Center Frankfurt, St. Katharinen Hospital, Frankfurt, Germany

and more 1 locations

Shockless Implant Evaluation

Not Applicable

Completed

Conditions: Ventricular Tachycardia
Ventricular Fibrillation

Interventions: Device: Implantable defibrillator

First Posted Date: 2008-12-02

Last Posted Date: 2018-03-30

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 2500

Registration Number: NCT00800384

Locations: 🇦🇺
The Royal Melbourne Hospital, Melbourne, Australia
🇦🇹
Landesklinikum St. Poelten, St. Poelten, Austria
🇦🇹
Allgemeines Krankenhaus Wien, Vienna, Austria

and more 82 locations

A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters

Completed

Conditions: Venous Thrombosis
Thrombosis
Peripheral Vascular Diseases

First Posted Date: 2008-10-23

Last Posted Date: 2014-10-17

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 452

Registration Number: NCT00778336

The Optical Coherence Tomography Drug Eluting Stent Investigation

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Device: JACTAX Drug eluting stent
Device: JACTAX LD drug eluting stent
Device: Taxus Libertè

First Posted Date: 2008-10-21

Last Posted Date: 2017-03-01

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 60

Registration Number: NCT00776204

Locations: 🇮🇹
Ospedali Riuniti di Bergamo, Bergamo, Italy

Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence

Phase 2

Completed

Conditions: Varicose Veins

Interventions: Drug: Varisolve (Polidocanol Endovenous Microfoam)
Drug: Agitated Saline

First Posted Date: 2008-09-25

Last Posted Date: 2021-04-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 77

Registration Number: NCT00758420

Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients

Terminated

Conditions: Heart Failure

Interventions: Device: Cardiac Resynchronization Therapy Defibrillator

First Posted Date: 2008-09-23

Last Posted Date: 2009-11-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 56

Registration Number: NCT00758121

Locations: 🇺🇸
San Diego Cardiac Center, San Diego, California, United States
🇧🇪
UZ Brussel, Brussels, Belgium

APPROPRIATE - Rate Adaptive Pacing Sensor

Not Applicable

Terminated

Conditions: Heart Diseases

Interventions: Device: Rate adaptive pacemaker

First Posted Date: 2008-09-23

Last Posted Date: 2017-06-14

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 566

Registration Number: NCT00757666

Locations: 🇺🇸
Cardiology Association of NE Arkansas, Jonesboro, Arkansas, United States
🇺🇸
Genesis Heart Institute, Davenport, Iowa, United States

"JACTAX" Trial Drug Eluting Stent Trial

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Device: JACTAX DES

First Posted Date: 2008-09-18

Last Posted Date: 2017-03-01

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 103

Registration Number: NCT00754728

Locations: 🇩🇪
Universitatsklinikum Bonn, Bonn, Germany
🇩🇪
Hamburg University CardioVascular Center, Hamburg, Germany
🇩🇪
HELIOS Klinikum, Siegburg, Germany

and more 2 locations

JACTAX LD Drug Eluting Stent Trial

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Device: JACTAX LD DES
Device: TAXUS™ Libertè™ DES

First Posted Date: 2008-09-18

Last Posted Date: 2017-03-01

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 130

Registration Number: NCT00754975

Locations: 🇩🇪
Universitatsklinikum Bonn, Bonn, Germany
🇩🇪
Cardiovascular Center Sankt Katharinen, Frankfurt, Germany
🇩🇪
Hamburg University CardioVascular Center, Hamburg, Germany

and more 2 locations

Spy II Clinical Registry

Completed

Conditions: Biliary Tract Diseases

Interventions: Device: SpyGlass

First Posted Date: 2008-09-12

Last Posted Date: 2021-08-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 297

Registration Number: NCT00751998

Locations: 🇺🇸
California Pacific Medical Center, San Francisco, California, United States
🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸
Indiana University Medical Center, Indianapolis, Indiana, United States

and more 12 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy